# DEPAKOTE ER
> **NDA022267** · New Drug Application · Sponsor: ABBVIE INC · Approved 2008-03-24
## Drug
- **FDA Application Number:** NDA022267
- **Application type:** New Drug Application
- **Brand name:** DEPAKOTE ER
- **Generic name:** Divalproex Sodium
- **Active ingredients:** DIVALPROEX SODIUM
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ABBVIE INC
- **First approval:** 2008-03-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022267)
---
*MORVS · CC0 1.0*